Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma

British Journal of Cancer

Volumn 86, Issue 8, 2002, Pages 1270-1275

  Rohloff, J ^a   Zinke, J ^a   Schoppmeyer, K ^a   Tannapfel, A ^a   Witzigmann, H ^a   Mossner J ^a   Wittekind, C ^a   Caca, K ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Hepararanase; Pancreatic ductal adenocarcinoma; Postoperative survival

Indexed keywords

HEPARANASE; TUMOR MARKER;

ADENOCARCINOMA; ANGIOGENESIS; ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADENOCARCINOMA; BLOTTING, WESTERN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCURONIDASE; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHATIC METASTASIS; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED;

EID: 0037156954     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600232     Document Type: Article

References (38)

1. Chemotherapy for pancreatic carcinoma
2. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
3. Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor kappa B
4. Results of resection of cancer of the exocrine pancreas: A study from the French association of surgery
5. Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer
6. Improvement in survival and clinical benefit with gemcitabine as first line therapy for patients with advanced pancreas cancer: A randomized trial
7. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in PDA
8. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer
9. Changing views of the role of matrix metalloproteinases in metastasis
10. Prognostic factors in pancreatic carcinoma
11. Survival in 1001 patients with carcinoma of the pancreas
12. Heparanase, a potent regulator of cell matrix interactions
13. The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma
14. Heparanase as mediator of angiogenesis: Mode of action
15. Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma
16. Molecular behaviour adapts to context: Heparanase functions as an extracellular matrix-degrading enzyme or as a T cell adhesion molecule, depending on the local pH
17. Expression of heparanase, Mdm2, and erbB2 in ovarian cancer
18. Genetic alterations of the transforming growth factor β receptor genes in pancreatic and biliary adenocarcinomas
19. Expression pattern and secretion of human and chicken heparanase are determined by their signal peptide sequence
20. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis
21. Adjuvant or neoadjuvant therapy for pancreatic carcinoma?
22. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following resection
23. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC gastrointestinal tract cancer cooperative group
24. Ductal adenocarcinoma of the pancreas
25. Heparanase expression in primary, and metastatic pancreatic cancer
26. Role of polypeptide growth factors and their receptors in human pancreatic cancer
27. Inhibition of heparanase activity and tumor metastasios by laminarin sulfate and synthetic phophorothioate oligodeoxynucleotides
28. Pancreatic cancer
29. Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase assays
30. Heparanase: A key enzyme involved in cell invasion
31. p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions
32. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas
33. Relationship between heparanase activity, and increasing metastatic potential of fibroblasts transfected with various oncogenes
34. Survival after pancreatoduodenectomy
35. Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis
36. Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis